Magellan Stock Valuation


USD 94.99  0.00  0.00%   

What is the current enterprise value of Magellan Health? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Magellan Health, is its stock price multiplied by the total number of shares outstanding, calculating Magellan Health's enterprise value requires a different approach. It uses Magellan Health's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Free Cash Flow is expected to rise to about 465.6 M this year, although Enterprise Value will most likely fall to about 2.6 B.
Magellan Health secures a last-minute Real Value of $87.81 per share. The latest price of the firm is $94.99. At this time, the firm appears to be overvalued. Our model forecasts the value of Magellan Health from analyzing the firm fundamentals such as Current Valuation of 2.09 B, profit margin of 6.26 %, and Return On Equity of (0.16) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Magellan Health Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Magellan Health's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Today 94.99
Please note that Magellan Health's price fluctuation is very steady at this time. Calculation of the real value of Magellan Health is based on 3 months time horizon. Increasing Magellan Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Magellan Health is useful when determining the fair value of the Magellan stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Magellan Health. Since Magellan Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Magellan Stock. However, Magellan Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Magellan Health helps investors to forecast how Magellan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Magellan Health more accurately as focusing exclusively on Magellan Health's fundamentals will not take into account other important factors:
Band Projection (param)
LowerMiddle BandUpper
LowEstimated ValueHigh
LowNext ValueHigh
1 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Magellan Health's intrinsic value based on its ongoing forecasts of Magellan Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Magellan Health's closest peers. When choosing an evaluation method for Magellan Health, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Magellan Health Investments

173.25 Million


Magellan Valuation Drivers Correlation

Many accounts on the financial statements of Magellan Health are highly interrelated and sometimes correlated. Consequently, when conducting Magellan's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Magellan
Click cells to compare fundamentals

Magellan Valuation Trend

Knowing Magellan Health's actual value is paramount for traders to make sound investment determinations. Magellan Health's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Magellan Health's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Magellan Health's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Magellan Market Cap

Magellan Health is rated below average in market capitalization category among related companies. Market capitalization of Healthcare Plans industry is now estimated at about 504.64 Billion. Magellan Health adds roughly 2.5 Billion in market capitalization claiming only tiny portion of equities under Healthcare Plans industry.
Capitalization  Total debt  Valuation  Revenue  Workforce

Magellan Health Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Magellan Health's current stock value. Our valuation model uses many indicators to compare Magellan Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Magellan Health competition to find correlations between indicators driving Magellan Health's intrinsic value. More Info.
Magellan Health is rated below average in price to book category among related companies. It is rated below average in price to earning category among related companies reporting about  6.58  of Price to Earning per Price to Book. Magellan Health Price to Earnings Ratio are quite stable at the moment as compared to the past year. The company's current value of Price to Earnings Ratio is estimated at 6.46. Earnings before Tax is expected to rise to about 328 M this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to about 446.5 M.. Comparative valuation analysis is a catch-all model that can be used if you cannot value Magellan Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Magellan Health's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Magellan Health's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Magellan Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Magellan Health and how it compares across the competition.

About Magellan Health Valuation

The equity valuation mechanism determines the current worth of Magellan Health on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Magellan Health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Magellan Health based exclusively on its fundamental and basic technical indicators. By analyzing Magellan Health's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Magellan Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Magellan Health. We calculate exposure to Magellan Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Magellan Health's related companies.
Last ReportedProjected for 2022
Gross Profit106.9 M145.5 M
Profit Margin 0.08  0.08 
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation. Magellan Health operates under Healthcare Plans classification in the United States and is traded on NASDAQ Exchange. It employs 9000 people.

Magellan Health Quarterly Enterprise Value

2.33 Billion


Magellan Health Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Magellan Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.44
Earnings Quarterly Growth-49.00%
Revenue Growth7.20%
Enterprise Value To Ebitda24.10
Earnings Growth-93.30%
Enterprise Value To Revenue0.43

Magellan Health Current Valuation Indicators

Valuation refers to the process of determining the present value of Magellan Health and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Magellan we look at many different elements of the entity such as Magellan's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Magellan Health's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Magellan Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Magellan Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Magellan Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Magellan Health's worth.
Additionally, see Stocks Correlation. Note that the Magellan Health information on this page should be used as a complementary analysis to other Magellan Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Tools for Magellan Stock

When running Magellan Health price analysis, check to measure Magellan Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Magellan Health is operating at the current time. Most of Magellan Health's value examination focuses on studying past and present price action to predict the probability of Magellan Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Magellan Health's price. Additionally, you may evaluate how the addition of Magellan Health to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences